PRETRANSPLANTATION BURDEN OF LEUKEMIC PROGENITOR CELLS AS A PREDICTOR OF RELAPSE AFTER BONE-MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC-LEUKEMIA

被引:90
作者
UCKUN, FM
KERSEY, JH
HAAKE, R
WEISDORF, D
NESBIT, ME
RAMSAY, NKC
机构
[1] UNIV MINNESOTA, HLTH SCI CTR, BONE MARROW TRANSPLANT PROGRAM, MINNEAPOLIS, MN 55455 USA
[2] UNIV MINNESOTA, HLTH SCI CTR, DEPT PEDIAT, MINNEAPOLIS, MN 55455 USA
[3] UNIV MINNESOTA, HLTH SCI CTR, DEPT THERAPEUT RADIOL RADIAT ONCOL, MINNEAPOLIS, MN 55455 USA
[4] UNIV MINNESOTA, HLTH SCI CTR, DEPT MED, MINNEAPOLIS, MN 55455 USA
关键词
D O I
10.1056/NEJM199310283291802
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. We developed a test to discern small numbers of residual leukemic progenitor cells in the bone marrow of patients with acute lymphoblastic leukemia (ALL) in remission. Preliminary studies revealed that before undergoing bone marrow transplantation such patients differed in their burden of leukemic progenitor cells. These observations suggested that the burden of these cells might influence the risk of relapse after transplantation. Methods. The number of residual leukemic progenitor cells before bone marrow transplantation was determined for 83 patients with high-risk ALL. We combined multiparameter flow cytometry and cell sorting with assays for leukemic progenitor cells in a quantitative method for the detection of minimal residual disease. Results. The count of leukemic progenitor cells in bone marrow specimens from patients in remission varied markedly between patients, ranging from 0 to 12,546 cells per million mononuclear cells, or from 0 to 1.255 percent (median, 51 leukemic progenitor cells per million mononuclear cells, or 0.005 percent). Patients whose count of leukemic progenitor cells exceeded the median value had a higher likelihood of relapse than did patients with values below the median (relapse rate at one year, 100 percent vs. 41 percent; P<0.001). There was a statistically significant inverse relation between the leukemic progenitor-cell content of bone marrow before transplantation and the duration of remission after transplantation (P<0.001). The estimated risk of relapse for patients with greater-than-or-equal-to 51 leukemic progenitor cells per million mononuclear cells was more than 3.5 times the risk for patients with lower counts, after adjustment for the effects of other covariates (P = 0.005). Conclusions. The count of residual leukemic progenitor cells is a powerful predictor of relapse after autologous bone marrow transplantation, particularly among male patients. Its measurement may be useful for analyzing and improving the treatment of patients with high-risk ALL in remission.
引用
收藏
页码:1296 / 1301
页数:6
相关论文
共 11 条
[1]  
CHAMPLIN R, 1989, BLOOD, V73, P2051
[2]  
COX DR, 1972, J R STAT SOC B, V34, P187
[3]   DETECTION OF RESIDUAL ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS IN CULTURES OF BONE-MARROW OBTAINED DURING REMISSION [J].
ESTROV, Z ;
GRUNBERGER, T ;
DUBE, ID ;
WANG, YP ;
FREEDMAN, MH .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (09) :538-542
[4]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[5]   COMPARISON OF AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR TREATMENT OF HIGH-RISK REFRACTORY ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
KERSEY, JH ;
WEISDORF, D ;
NESBIT, ME ;
LEBIEN, TW ;
WOODS, WG ;
MCGLAVE, PB ;
KIM, T ;
VALLERA, DA ;
GOLDMAN, AI ;
BOSTROM, B ;
HURD, D ;
RAMSAY, NKC .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (08) :461-467
[6]  
MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
[7]  
MILLER CB, 1991, BLOOD, V78, P1125
[8]  
NEGRIN RS, 1991, BLOOD, V78, P255
[9]  
UCKUN FM, 1990, BLOOD, V76, P1723
[10]  
UCKUN FM, 1992, BLOOD, V79, P1094